Thalidomide for the treatment of COVID-19 pneumonia: A randomized controlled clinical trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Thalidomide for the treatment of COVID-19 pneumonia: A randomized controlled clinical trial

Published:2023 Issue:1 Volume:12 Page:14
ISSN:2277-9175
Container-title:Advanced Biomedical Research
language:en
Short-container-title:Adv Biomed Res

Author:

Pourajam Samaneh,Amra Babak,Ashrafi Farzaneh,Torki Mehdi,Hashemi Marzieh,Shirzadi Mohamad,Soltaninejad Forogh,Sadeghi Somayeh,Salmasi Mehrzad,Sami Ramin,Darakhshandeh Ali,Nasirian Maryam

Publisher

Medknow

Subject

General Biochemistry, Genetics and Molecular Biology

Reference18 articles.

1. The deadly coronaviruses: The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in China;Yang;J Autoimmun,2020

2. Virology, epidemiology, pathogenesis, and control of COVID-19;Jin;Viruses,2020

3. The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China;Zhang;J Clin Immunol,2020

4. WHO (2020). Coronavirus Disease 2019. WHO

5. (2020). Available from: https://www.who.int/emergencies/diseases/novel-coronavirus-2019. [Last accesed on 2020 Oct 26].

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP